Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.
Medifast, Inc. (NYSE: MED), established in 1980, is a renowned nutrition and weight loss company based in Maryland. With the endorsement of over 20,000 doctors, Medifast is a trusted name in the industry, known for its clinically proven products developed by physicians. The company's mission is to empower individuals to lead healthier lives by providing effective weight loss and management solutions.
Medifast offers a diverse range of support programs tailored to meet the unique needs and goals of its customers. These programs are designed to help individuals achieve their health and wellness objectives through personalized guidance and scientifically backed products. The company’s vision is to create a world where people can easily take control of their own well-being, believing that healthier individuals lead happier lives.
One of the core aspects of Medifast's approach is its commitment to producing results and helping people succeed on their wellness journeys. The company generates revenue primarily through e-commerce transactions, where it sells various health and nutritional products aimed at promoting weight loss, weight management, and overall healthy living.
Recent achievements of Medifast include expanding its product line to cater to a broader audience and forming strategic partnerships to enhance its distribution network. The company’s current projects focus on leveraging technology to provide more personalized and accessible health solutions to its customers. Financially, Medifast has shown resilience and growth, reflecting its strong market position and the effectiveness of its business strategies.
Medifast's dedication to changing lives is evident in the numerous success stories of individuals who have transformed their health and well-being through its programs. By providing the right opportunities and support, Medifast continues to make a significant impact on the lives of many, fostering a sense of joy and achievement among its customers.
Medifast reported robust financial results for Q4 and FY 2021, with a 42.6% increase in quarterly revenue to $377.8 million and a 63.2% rise in annual revenue to $1.526 billion. Net income surged 21.5% in Q4 to $34.0 million and 59.5% for the year to $164.0 million. Diluted EPS reached $2.91 in Q4, up 23.3%, and $13.89 annually, an increase of 60.0%. However, gross profit margin fell 1.5% percentage points due to inflation impacts. The company expects FY 2022 revenue between $1.72 billion and $1.79 billion.
Medifast, Inc. (NYSE: MED) will announce its financial results for Q4 and full year 2021 on February 23, 2022, after market close. The conference call will start at 4:30 p.m. ET, featuring CEO Dan Chard and CFO Jim Maloney discussing the results. This announcement is crucial for investors as it provides insights into the company's financial performance and future outlook. The call can be accessed via Medifast's website, and there will be a playback option available until March 2, 2022. For more information, visit MedifastInc.com.
Medifast, Inc. (NYSE: MED) announced that CEO Dan Chard and CFO Jim Maloney will present at the 2022 ICR Conference on January 11, 2022, at 2:30 p.m. ET. The presentation will be live-streamed on Medifast's Investor Relations website and archived until January 25, 2022. Medifast is recognized for its OPTAVIA® health and wellness community, emphasizing lifelong transformation through healthy habits. The company has received accolades such as FORTUNE's 100 Fastest-Growing Companies and was named one of Forbes' 100 Most Trustworthy Companies in America.
Medifast (NYSE: MED) released a survey indicating that only 10% of U.S. adults successfully maintain their New Year's resolutions, with 47% breaking theirs within the first month. The intention to set resolutions has dropped to 44% in 2022 from 50% in 2021, attributed mainly to lack of motivation. The survey shows a shift towards manageable lifestyle changes; 58% of respondents prefer gradual habit changes, and 66% favor smaller daily adjustments over quick diets. Medifast's OPTAVIA® supports this approach through community and coaching.
Medifast, Inc. (NYSE: MED) has declared a $1.42 quarterly cash dividend, payable on February 8, 2022, to stockholders of record by December 21, 2021. The company aims to maintain a quarterly dividend program, subject to the Board's discretion. Medifast is known for its health and wellness community, offering OPTAVIA® products and coaching. The company has been recognized in various industry rankings, including FORTUNE's 100 Fastest-Growing Companies list.
Medifast reported robust Q3 2021 results, showcasing a 52.3% revenue increase to $413.4 million compared to Q3 2020. Active OPTAVIA Coaches grew 44.9% to 61,000, with revenue per Coach rising 7.0% to $6,773. Net income surged 21.9% to $42.0 million, yielding an EPS of $3.56, up 22.3%. Despite these gains, gross profit margin slightly decreased to 74.3% and SG&A expenses climbed 57.9%. The company anticipates full-year revenue between $1.51 billion and $1.53 billion.
Medifast, Inc (NYSE: MED) will announce its third-quarter financial results for the period ending September 30, 2021, on November 4, 2021, after the market closes. The conference call, featuring CEO Dan Chard and CFO Jim Maloney, will begin at 4:30 p.m. ET, accessible via their website or by phone. Medifast is recognized for its OPTAVIA® health and wellness community, which has influenced 2 million lives, offering scientifically developed products and support for healthy habits.
Medifast (NYSE: MED) hosted its third annual Healthy Habits For All Week from September 20-26, 2021, aimed at improving health education and access in underserved communities. The event included employee volunteers distributing back-to-school bags and Chromebooks to local students in Baltimore. Medifast collaborated with nonprofits like No Kid Hungry, raising over $900,000 to provide up to 9 million meals for children in need. CEO Dan Chard emphasized the initiative's alignment with the company's mission to promote wellness among future generations.
FAQ
What is the current stock price of Medifast (MED)?
What is the market cap of Medifast (MED)?
What is Medifast, Inc.?
How does Medifast generate its revenue?
What is the mission of Medifast?
What kind of support programs does Medifast offer?
Where is Medifast, Inc. headquartered?
Who founded Medifast, Inc.?
What are some recent achievements of Medifast?
What is Medifast's vision?
What makes Medifast's approach effective?
How long has Medifast been in operation?
